Global Blood Therapeutics is a privately held company that is focused on building a pipeline of oral medicines to revolutionize the treatment of chronic blood-based diseases and severe genetic disorders for which there are currently no cures available and only extremely limited therapeutic options. Global Blood Therapeutics was formed by its $40.7 million venture investment from Third Rock Ventures.
Overview & Corporate Organization
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Charts, Financials, and Statistics (Table Format)
Copy & Paste Financials Into Spreadsheet or Export All Global Blood Therapeutics Financials To Excel
|*||Global Blood Therapeutics fiscal year end: 12/31|
|Jun. 2012||View||A||Venture Capital|
|Details||Total Round A View|
|Total of Funding Shown Above View|
Missing a deal? Tell us about it! email@example.com